Implantable Defibrillators Configured for Hybrid Therapy of Persistent and Permanent Atrial Fibrillation: Initial Clinical Experience with a Novel Lead System

  • Hygriv B. Rao
  • Sanjeev Saksena


Aim: Hybrid therapy strategies have combined antiarrhythmic drugs (AAD) with pacemakers, atrio-ventricular defibrillators (AV ICD) or atrial ablation individually. The feasibility combining AAD with dual site RA pacing (DAP) in an AV ICD has not been examined.

Methods: We used an AV ICD with a novel lead configuration permitting DAP, antitachycardia pacing (ATP) or atrial shocks (ADF) in patients (pts) with refractory persistent or permanent AF. Hybrid therapy included linear RA ablation and/or focal ablation. Continuous DAP and automatic ATP with patient or physician activated ADF.

Results: 24 pts, mean age 66 ± 10 yrs, with cardiac disease (22 pts), underwent insertion of an AVICD with dual RA leads. 20 patients had concomitant ablative procedures (RA only = 19, RA + LA = 1) and all pts continued previously ineffective AAD. During a follow-up of 2–36 months (mean 17 ± 8 mos), rhythm control was restored in all pts & maintained long-term in 19 (83%) pts. 8 pts used AF termination therapies successfully. Device datalogs showed no episodes of AF in 6 pts, asymptomatic brief arrhythmias in 4 pts, infrequent paroxysmal AF in 9 pts & persistent AF recurred in 5 pts. AV ICD detection algorithms reliably detected AF or AT in the DAP mode in all pts. Intermittent brief P wave double counting occurred during AT in selected pts. No pt received inappropriate ADF therapy.

Conclusions: 1. DAP can be safely incorporated in an AVICD devices for use in an hybrid therapy strategy for AF pts. 2. These devices can be effective for both AF prevention & termination. 3. Long term rhythm control can be achieved and documented by device datalogs in persistent and permanent AF.


multisite pacing atrial fibrillation tachycardias implantable defibrillators therapy of arrhythmias hybrid therapy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347(23):1834–1840.CrossRefPubMedGoogle Scholar
  2. 2.
    Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, et al. STAF Investigators. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003;41:1690–1696.CrossRefPubMedGoogle Scholar
  3. 3.
    Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S, etal. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002;105(9):1077–1081.CrossRefPubMedGoogle Scholar
  4. 4.
    Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, etal. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004;351(23):2373–2383.CrossRefPubMedGoogle Scholar
  5. 5.
    Domanski MJ, Zipes DP, Benditt DG, Camm AJ, Exner DV, Ezekowitz MD, Greene HL, Lesh MD, Miller JM, Pratt CM, Saksena S, Scheinman MM, Singh BN, Tracy CM, Waldo AL: Central clinical research issues in electrophysiology: report of the NASPE Committee. Pacing Clin Electrophysiol 2001;24(4 Pt 1):526–534.CrossRefPubMedGoogle Scholar
  6. 6.
    Bardy GH, Lee KL, Mark DM et al, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Eng J Med 2005:352:225–237.CrossRefGoogle Scholar
  7. 7.
    Filipecki A, Saksena S and Lin WH, Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation. Am J Cardiol 2003;92:1037–1044.CrossRefPubMedGoogle Scholar
  8. 8.
    Madan N and Saksena S, Long-term rhythm control of drug refractory atrial fibrillation with “hybrid therapy” incorporating dual site right atrial pacing, antiarrhythmic drugs, and right atrial ablation. Am J Cardiol 2004;93:569–575.CrossRefPubMedGoogle Scholar
  9. 9.
    Schoels W, Swerdlow CD, Jung W, et al., Worldwide clinical experience with a new dual chamber implantable cardioverter-defibrillator system. J Cardiovasc Electrophysiol 2001;12(5):521–528.CrossRefPubMedGoogle Scholar
  10. 10.
    Ricci R, Pignalberi C, Disertori M, et al., Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life threatening ventricular tachyarrhythmias. Eur Heart J 2002;23(18):1471–149.CrossRefPubMedGoogle Scholar
  11. 11.
    Saksena S, Prakash A, Ziegler P, Hummel JD, Friedman P, Plumb VJ, Wyse DG, Johnson E, Fitts S, Mehra R. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002;;40(6):1140–1150.CrossRefPubMedGoogle Scholar
  12. 12.
    Fitts SM, Hil MR,Mehra R, Friedman P, Hammil S, Kay GN, Prakash A etal., Design and Implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) Clinical Trial. J Interven Cardiac Electrophysiol 1998;2:139–144.CrossRefGoogle Scholar
  13. 13.
    Fuster V, Ryden LE, Asinger RW, Cannom DS etal., ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American college of Cardiology/American Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. J Am Coll Cardiol 2001;38:1231–1266.CrossRefPubMedGoogle Scholar
  14. 14.
    Saksena S, Skadsberg N, Rao BH, Filipecki A, Biatrial and 3-Dimensional Mapping of Spontaneous Atrial Arrhythmias in Patients with Refractory Atrial Fibrillation. J Cardiovasc Electrophysiol May 2005 (in press).Google Scholar
  15. 15.
    Schimtt C, Montero M, Melicherick J, Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. Pacing Clin Electrophysiol 1998;17:295–302.Google Scholar
  16. 16.
    Lee MA, Weachter R, Pollak S, Kremers MS, Naik AM, Silverman R, Tuzi J, Wang W, Johnson LJ, Euler DE, ATTEST Investigators. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: Results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 2003;41(11):1926–1932.CrossRefPubMedGoogle Scholar
  17. 17.
    Mitchell ARJ, Spurrell PAR, Cheatle L, Sulke N, Effect of atrial antitachycardia pacing treatments in patients with an atrial defibrillator: Randomised study comparing subthreshold and nominal pacing outputs. Heart 2002:87:433–437.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Hygriv B. Rao
    • 1
  • Sanjeev Saksena
    • 1
  1. 1.The Electrophysiology Research Foundation, Warren, Arrhythmia and Pacemaker Service, Eastern Heart Institute, Passaic, Department of MedicineRobert Wood Johnson University HospitalNew BrunswickUSA

Personalised recommendations